IDO1 is under genetic control of the cancer-suppression gene bridging integrator 1 (Bin1), and Bin1 knockout results in tumor growth and immune suppression in mice by upregulating STAT1- and NF-κB-dependent expression of IDO1 [20]. The gene discussed is IDO1; the disease is neoplasm.